Abstract:Nanomedicine, an area that uses nanomaterials for theragnostic purposes, is advancing rapidly, particularly in the detection and treatment of neurodegenerative diseases. The design of nanocarriers can be optimized to enhance drug bioavailability and targeting to specific organs, improving therapeutic outcomes. However, clinical translation hinges on biocompatibility and safety. Nanocarriers can cross the blood-brain barrier (BBB), potentially causing neurotoxic effects through mechanisms such as oxidative stress, DNA damage, and neuroinflammation. Concerns about their accumulation and persistence in the brain make it imperative to carry out a nanotoxicological risk assessment. Generally, this involves identifying exposure sources and routes, characterizing physicochemical properties, and conducting cytotoxicity assays both in vitro and in vivo. The lack of a specialized regulatory framework creates substantial gaps, making it challenging to translate findings across development stages. Additionally, there is a pressing need for innovative testing methods due to constraints on animal use and the demand for high-throughput screening. This review examines the mechanisms of nanocarrier-induced neurotoxicity and the challenges in risk assessment, highlighting the impact of physicochemical properties and the advantages and limitations of current neurotoxicity evaluation models. Future perspectives are also discussed. Additional guidance is crucial to improve the safety of nanomaterials and reduce associated uncertainty. STATEMENT OF SIGNIFICANCE: Nanocarriers show tremendous potential for theragnostic purposes in neurological diseases, enhancing drug targeting to the brain, and improving biodistribution and pharmacokinetics. However, their neurotoxicity is still a major field to be explored, with only 5% of nanotechnology-related publications addressing this matter. This review focuses on the issue of neurotoxicity and safety assessment of nanocarriers for brain delivery. Neurotoxicity-relevant exposure sources, routes, and molecular mechanisms, along with the impact of the physicochemical properties of nanomaterials, are comprehensively described. Moreover, the different experimental models used for neurotoxicity evaluation are explored at length, including their main advantages and limitations. To conclude, we discuss current challenges and future perspectives for a better understanding of risk assessment of nanocarriers for neurobiomedical applications.

Molecular mechanisms of silver nanoparticle-induced neurotoxic injury and new perspectives for its neurotoxicity studies: A critical review

The progress of silver nanoparticles in the antibacterial mechanism, clinical application and cytotoxicity

Silver Nanoparticles Induced Hippocampal Neuronal Damage Involved in Mitophagy, Mitochondrial Biogenesis and Synaptic Degeneration.

A Review on the Toxicity of Silver Nanoparticles Against Different Biosystems.

Neurotoxicity concern about the brain targeting delivery systems

Mechanisms of Silver Nanoparticle Release, Transformation and Toxicity: A Critical Review of Current Knowledge and Recommendations for Future Studies and Applications

Nanoparticles and neurodegeneration: Insights on multiple pathways of programmed cell death regulated by nanoparticles

Mechanisms of nanosilver-induced toxicological effects: more attention should be paid to its sublethal effects.

Unraveling the neurotoxicity of titanium dioxide nanoparticles: focusing on molecular mechanisms

Neurotoxicities induced by micro/nanoplastics: A review focusing on the risks of neurological diseases

Silver Nanoparticle-Induced Impaired Autophagic Flux and Lysosomal Dysfunction Contribute to the Microglia Inflammation Polarization

A review on silver nanoparticles-induced ecotoxicity and the underlying toxicity mechanisms

Silver Nanoparticles Induced Neurotoxicity Through Oxidative Stress in Rat Cerebral Astrocytes is Distinct from the Effects of Silver Ions.

Nano Silver-Induced Toxicity and Associated Mechanisms

Silver Nanoparticles Induced Synaptic Degeneration Via Ca2+/CaMKII Signal and Drp1-dependent Mitochondrial Disorder in HT22 Cells

Involvement of Programmed Cell Death in Neurotoxicity of Metallic Nanoparticles: Recent Advances and Future Perspectives

The inflammatory response to silver and titanium dioxide nanoparticles in the central nervous system.

Silver nanoparticles induced synaptic degeneration via Ca 2+ /CaMKII signal and Drp1-dependent mitochondrial disorder in HT22 cells

Silver Nanoparticles Induced Cytotoxicity in HT22 Cells Through Autophagy and Apoptosis Via PI3K/AKT/mTOR Signaling Pathway

Potential neurotoxicity of nanoparticles.

Navigating Neurotoxicity and Safety Assessment of Nanocarriers for Brain Delivery: Strategies and Insights